We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.newsWe've updated our Privacy Policy with additional info on research surveys, our browser extension, cookie management, and ad performance measurement. Questions? Email us any time at privacy@ground.news
Published 2 days ago • loading... • Updated 2 days ago
HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results
Preliminary Phase 1 data showed signs of Treg activation and improvement in some alopecia areata patients, while no dose-limiting toxicities were reported.